SB3131: ORPHAN Cures Act Optimizing Research Progress Hope And New Cures Act
- 1Introduced (current step)
- 2Passed One Chamber
- 3Passed Both Chambers
- 4Became Law
Here is how to read this bill
Start with the summary
It says what the bill does in plain language. The official text is one tab over.
Check where it is
The status badge says how far it has gotten. The History tab lists every step.
Follow it
We will email you when it moves. You need a free account.
Tell someone who votes on it
Email or call the sponsor, or find your own representatives, from the actions panel.
Bill information
Summary
A bill to amend title XI of the Social Security Act to expand and clarify the exclusion for orphan drugs under the Drug Price Negotiation Program.
Plain-language summary
This bill modifies a federal law to exclude orphan drugs from the government's drug price negotiation program. Orphan drugs treat rare diseases that affect small patient populations. The bill expands and clarifies which drugs qualify for this exclusion from price negotiations. It affects the Medicare drug price negotiation program created by recent healthcare legislation. The bill is currently in the introduced stage, meaning it has been formally submitted to Congress but has not yet been reviewed by a .
AI-generated summary
What can I do?
It's early in the process — messages to the sponsor and your representatives carry the most weight right now.
Contact Your Representatives
Calling or emailing is the most direct way to weigh in — offices tally constituent contacts.
Find Your RepresentativesShare This Bill
Sharing helps others in your district get informed and involved.
SB3131: ORPHAN Cures Act Optimizing Research Progress Hope And New Cures Act
Upcoming hearings & events
Sponsors
John Barrasso
Primary SponsorCo-sponsors (3)
Thomas Carper
Roger Marshall
Ted Budd